in vivo ≠ in vitro [Power / Sample Size]

posted by Helmut Homepage – Vienna, Austria, 2022-07-25 09:56 (19 d 05:34 ago) – Posting: # 23167
Views: 290

Hi Mithu,

» Is it advisable to have little large sample size …

Larger than what?

» … for molecules falls under BCS Class II and IV? especially when routine 2WC design is selected?

Only in a few cases of BCS class II drugs (under certain conditions) there is an in vivo in vitro correlation. For BCS class IV drugs never. You plan the study always based on the in vivo variability and T/R-ratio for a desired power. In other words, BCS does not play any role.

Dif-tor heh smusma 🖖 [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
22,301 posts in 4,667 threads, 1,585 registered users;
online 10 (0 registered, 10 guests [including 7 identified bots]).
Forum time: Saturday 15:30 CEST (Europe/Vienna)

In the field of observation,
chance favors only the mind that is prepared.    Louis Pasteur

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz